Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients
Open Access
- 30 March 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (16) , 14374-14384
Abstract
CD22 is a member of the Sialic acid-binding Ig-like lectin (Siglec) family of lectins described to be exclusively present in B lymphocytes and B cell-derived neoplasms. Here, we describe a novel splice form of CD22 (designated CD22∆N), which lacks the N-terminal domain as demonstrated by exon-specific RT-PCR and differential recognition by anti-CD22 antibodies. Importantly, CD22∆N mRNA is expressed in skin lesions from 39 out of 60 patients with cutaneous T cell lymphoma (CTCL), whereas few patients (6 out of 60) expresses full-length, wild type CD22 (CD22wt). In addition, IHC staining of tumor biopsies confirmed the expression of CD22 in CD4+ T cells. Moreover, four out of four malignant T cell lines express CD22: Two cell lines express CD22∆N (MyLa2059 and PB2B) and two express CD22wt (MAC-1 and MAC-2A). siRNA-mediated silencing of CD22 impairs proliferation and survival of malignant T cells, demonstrating a functional role for both CD22∆N and CD22wt in these cells.Keywords
This publication has 42 references indexed in Scilit:
- The role of AHI1 and CDKN1C in cutaneous T‐cell lymphoma progressionExperimental Dermatology, 2012
- Epitope mapping and key amino acid identification of anti-CD22 immunotoxin CAT-8015 using hybrid -lactamase displayProtein Engineering, Design and Selection, 2010
- Unexpected Role for the B Cell-Specific Src Family Kinase B Lymphoid Kinase in the Development of IL-17–Producing γδ T CellsThe Journal of Immunology, 2010
- Programmed cell death‐10 enhances proliferation and protects malignant T cells from apoptosisAPMIS, 2010
- Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinomaBMC Cancer, 2010
- Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell LymphomaClinical Cancer Research, 2010
- Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapseInternational Journal of Clinical Oncology, 2010
- Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphomaBlood, 2009
- Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcomeBlood, 2007
- Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxinsBlood, 2006